June 8, 2017 6:30pm

 

Or were all parties trying to “controlling the narrative”

 

... Reminds me of Biostage’s (BSTG) lack of disclosure … disrespecting shareholder’s ability to be made aware of material facts regarding a historical death  

 

Investors are getting spooked about the lack of “form and substance”

 

Pre-open indications re-cap: 7 hits and 3 miss

 

I answer one question, in which company should investors commit and keep their money.

Lose an advantage or be a subscriber!  Today’s results have implications to Wednesday's sector activity.  

 


 

A daily report may say little or a lot and its final judgement may be inconclusive; yet it serves as insurance that all indications are being examined and evaluated.

 

 

Henry’omics:

From the pre-open’s investor’s newsletter … “Loyalty - the word for today … faithfulness to commitments or obligations; do we need or expect just momentum to “lift the cloud”   In our realm of shareholder politics, it’s about expectation and follow-through made which doesn’t seem to be supported … So, what is the difference between some CEOs and politicians …?”

  • Reiterating, “Thursday’s events could lead to elevated volatility in the session, it’s a matter of perception and I believe a tone of government insecurity and market uncertainty.”

The low volume and upside volatility helped the sector as traders hoped for a spike on Thursday and got one!

  • Former FBI Director James Comey gave testimony before the Senate Intelligence Committee and tapped a number of issues but, it seem more about he said that he said with both individuals parading their views of each other.

What I saw was moral indignation from both individuals – the president and the former director of the FBI.

  • But, it seemed the market was slowed yet, unfazed to the – I believe – the battle of egos!

 

These political issues are taking the focus from healthcare, infrastructure and tax saving initiatives!

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was positive with an A/DL of 18/16 and 9 flats ;

·         The mid-day was positive with an A/DL of 26/15 and 2 flats;

·         The close was positive with an A/DL of 30/12 and 1  flat;

 

 

Pre-open indications re-cap:  7 hits and 3 miss …

  • Applied Genetic Technologies (AGTC) closed up +$0.15 – hit;
  • bluebird bio (BLUE) closed up +$1.85 – hit;
  • Cytori (CYTX) closed up +$0.04 – hit;
  • Juno Therapeutics (JUNO) closed down -$1.37 – miss;
  • Kite Therapeutics (KITE) closed up +$4.57 – hit;
  • Mesoblast (MESO) closed up +$0.60 – miss;
  • Organovo (ONVO) closed down -$0.11 – miss;
  • Regenxbio (RGNX) closed up +$0.25 – hit;
  • Stemline (STML) closed up + $0.05 – hit;
  • Verastem (VSTM) closed up +$0.08 – hit;

 

 

Daily analytics:

U.S. equities closed UP on Wednesday … with the DOW closing UP +0.04% (+4.84) as the NASDAQ also closed UP +0.39% (+24.38) …

… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, near 10.2 … 1.5% lower

· Wednesday traded near 10.32 - -1.24% after Tuesday’s 10.5, Monday’s near 9.8, Friday’s near 9.8, and last Thursday’s  below 10 …

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated a positive +0.32% at the pre-open and closed

·         Thursday traded UP +1.34%

·         Wednesday +0.10%

·         Tuesday -0.09%

·         Monday -0.55%

·         Friday +0.65%,

·         Thursday +1.93%,

… The iShares NASDAQ Biotechnology (IBB) did NOT indicated in the pre-open and closed

·         Thursday traded UP +0.63%

·         Wednesday +0.06%

·         Tuesday -0.46%

·         Monday -0.62%

·         Friday +1.68%

·         Last Thursday +1.80% …

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads ……….

·         Thursday’s decliners ranged from -0.30% <FATE> to -8.33% <ISCO> in 12 equities;

·         Wednesday’s decliners ranged from -0.45% <BLFS> to -7.72% <NWBO> in 21 equities;

·         Tuesday’s decliners ranged from -0.37% <ONCE> to -6.98% <NWBO> in 19 equities;

·         Monday’s decliners ranged from -0.16% <CLLS> to -10.74% <JUNO> in 30 equities;

·         Friday’s decliners ranged from -0.33% <ONCE> to -3.85% <ISCO> in 11 equities;

·         Last Thursday’s decliners ranged from -0.18% <QURE> to -3.17% <VTGN> in 10 equities;

Versus

·         Thursday’s gainers ranged from +0.12%  <CLLS> to +7.26% <MESO> in 30 equities;

·         Wednesday’s gainers ranged from +0.27%  <XON> to +11.15% <BLUE> in 16 equities;

·         Tuesday’s gainers ranged from +0.12%  <CLLS> to +7.56% <BLUE> in 18 equities;

·         Monday’s gainers ranged from +0.68% (+$0.01) <ATHX> to +8.50% <BLUE> in 10 equities;

·         Friday’s gainers ranged from +0.46% <VSTM> to +6.98% <JUNO> in 31 equities;

·         Last Thursday’s gainers ranged from +0.66% <MDXG> to +18.18% <ISCO> in 29 equities;

 

 

Some of MY working trend lines or indications for tomorrow:

… The greatest volume to the downside:  JUNO, ATHX, ONCE, VCEL and QURE

… Upside volume was weighted to:  RENE.L, KITE, BLUE, VSTM and MDXG

… Biggest $ downside:  JUNO, ONCE, OSIR, ONVO and ISCO

… Largest $ upside: KITE, BLUE, XON, AXGN and MESO

… Flats:  AST

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.